Mirtazapine: An Antidepressant for Treating Chronic, Refractory Nausea and Vomiting in a Patient With Metastatic Sarcoma Receiving Palliative Care: A Case Report
Managing chronic, refractory nausea and vomiting in advanced cancer patients is challenging, especially when unrelated to cancer treatment. Mirtazapine, a tetracyclic antidepressant, effectively alleviates these symptoms, improving quality of life. It offers a promising palliative care alternative, addressing multiple symptoms and reducing polypharmacy, thereby enhancing patient satisfaction.
Authors
- Mamak Tahmasebi (ORCID: https://orcid.org/0000-0001-6752-3314)
- Seyedeh Golnaz Ziaei (ORCID: https://orcid.org/0000-0003-0563-0215)
Institutions
- Imam Khomeini Hospital (IR)
- Tehran University of Medical Sciences (IR)
Publication Details
- Journal
- Clinical Case Reports
- Published
- 2024-11-01
- DOI
- https://doi.org/10.1002/ccr3.9570
- Citations
- 1
- Primary Topic
- Nausea and vomiting management
- Type
- article
- Field-Weighted Citation Impact
- 0.57
Funders
- University of California, San Francisco
- Department of Medicine, University of California, San Francisco